Treatment for Pediatric Obesity

Phase-Based Progress Estimates
1
Effectiveness
2
Safety
University of Minnesota, Minneapolis, MN
Pediatric Obesity+3 More
Eligibility
< 18
All Sexes
Eligible conditions
Select

Study Summary

This study is evaluating whether a medication may help adolescents with severe obesity.

See full description

Eligible Conditions

  • Pediatric Obesity
  • Obesity, Adolescent

Treatment Effectiveness

Effectiveness Estimate

1 of 3

Study Objectives

This trial is evaluating whether Treatment will improve 1 primary outcome in patients with Pediatric Obesity. Measurement will happen over the course of Baseline, 12-, 24-, 36-, and 48 weeks.

Week 48
Percent change in body mass index (BMI)

Trial Safety

Safety Estimate

2 of 3
This is better than 68% of similar trials

Trial Design

0 Treatment Group

This trial requires 150 total participants across 0 different treatment group

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, 12-, 24-, 36-, and 48 weeks
This trial has the following approximate timeline: 3 weeks for initial screening, variable treatment timelines, and roughly baseline, 12-, 24-, 36-, and 48 weeks for reporting.

Closest Location

University of Minnesota - Minneapolis, MN

Eligibility Criteria

This trial is for patients born any sex aged 18 and younger. There are 8 eligibility criteria to participate in this trial as listed below.

Mark “yes” if the following statements are true for you:
for fertile males and for females not of reproductive potential: highly effective contraception is not required For sexually active females of reproductive potential, they must agree to use a highly effective form of contraception, such as the oral contraceptive pill, IUD, or implant, during the course of the study show original
If you are a male of reproductive potential, you should use condoms or other methods to ensure effective contraception with your partner. show original
One legal parent or guardian must provide a signed and dated informed parental consent form in order for their child to participate in the study. show original
I am willing to comply with all the study procedures and I am available for the entire study duration. show original
A person has obesity if their BMI is greater than or equal to 1.2 times the 95th percentile or BMI is greater than or equal to 35 kilograms per meter squared, whichever is lower. show original
The Tanner stage is equal to or greater than 2. show original
A person who is either male or female and is aged between 12 and 17 years old at the time of consenting is considered to be a juvenile. show original
Provision of signed and dated informed assent form;

Patient Q&A Section

Ask a question about the study

Other questions from users

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any geographic restrictions to consider when applying for this trial?

Patients from any state can participate in this trial, so long as they are able to attend all treatment sessions.

Will my insurance cover participating in this trial?

In order to understand how insurance coverage works for this trial, you will need to contact the study coordinator.

See if you qualify for this trial
Get access to this novel treatment for Pediatric Obesity by sharing your contact details with the study coordinator.